Cleared Traditional

K232512 - Masimo W1

K232512 is an FDA 510(k) clearance for Masimo W1, manufactured by Masimo Corporation. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 91-day FDA review.

K232512 · Masimo Corporation · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2023
Decision
91d
Days
Class 2
Risk

K232512 is an FDA 510(k) clearance for the Masimo W1. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Masimo Corporation (Irvine, US). The FDA issued a Cleared decision on November 17, 2023 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Masimo Corporation devices

FDA 510(k) Submission Details - K232512

510(k) Number K232512 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2023
Decision Date November 17, 2023
Days to Decision 91 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 125d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPS Electrocardiograph

All 401
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K232512.
MCG-S (AM1000)
K232823 · Amcg Co., Ltd. · Apr 2024
Cardio Q50, Cardio Q70
K231160 · Bionet Co., Ltd. · Dec 2023
CARDIPIA ECG / Model: CARDIPIA400H, CARDIPIA800H
K230834 · Trismed Co., Ltd. · Nov 2023
EKGenius Smart System
K232974 · Ekgenius, LLC · Nov 2023
Cardio P1
K231150 · Bionet Co., Ltd. · Nov 2023
Withings Scan Monitor 2.0
K230812 · Withings · Aug 2023